Thymosin β4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro

Chest

Volumn 130, Issue 5, 2006, Pages 1433-1440

  Rubin, Bruce K ^a   Kater, Arnon P ^a,b,c   Goldstein, Allan L ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Actin; Cystic fibrosis; Dornase alfa; Sputum; Thymosins; Viscoelasticity

Indexed keywords

DNA; DORNASE ALFA; F ACTIN; THYMOSIN BETA4; ACTIN; DEOXYRIBONUCLEASE I; DNASE1 PROTEIN, HUMAN; THYMOSIN; THYMOSIN BETA(4);

ACTIN FILAMENT; ADHESION; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CORRELATION ANALYSIS; COUGHING; CYSTIC FIBROSIS; DEPOLYMERIZATION; DNA DAMAGE; FEMALE; FLOW KINETICS; HUMAN; IN VITRO STUDY; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; MUCOCILIARY TRANSPORT; PRIORITY JOURNAL; SPUTUM ANALYSIS; VISCOELASTICITY; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; LUNG; METABOLISM; PATHOLOGY; SPUTUM; TIME;

ACTINS; ADOLESCENT; ADULT; CYSTIC FIBROSIS; DEOXYRIBONUCLEASE I; DNA; FEMALE; HUMANS; LUNG; MALE; MICROSCOPY, CONFOCAL; RESPIRATORY FUNCTION TESTS; RHEOLOGY; SPUTUM; THYMOSIN; TIME FACTORS;

EID: 33751225093     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.5.1433     Document Type: Article

References (34)

1. King M. Is cystic fibrosis mucus abnormal? Pediatr Res 1981; 15:120-122
2. Lopez-Vidriero MT, Reid L. Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases. Am Rev Respir Dis 1978; 117:465-477
3. King M, Rubin BK. Mucus rheology: relationship with transport. In: Takishima T, Shimura S, eds. Airway secretion: physiological basis for the control of mucus hypersecretion. New York, NY: Marcel Dekker, 1994; 283-314
4. Lethem MI, James SL, Marriott C, et al. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 1990; 3:19-23
5. Vasconcellos CA, Allen PG, Wohl ME, et al. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994; 263:969-971
6. Shak S, Capon DJ, Hellmiss R, et al. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A 1990; 87:9188-9192
7. Ramsey BW, Astley SJ, Aitken ML, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994; 331:637-642
8. Gallon AM. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoractomy. Thorax 1996; 51:429-436
9. King M, Dasgupta B, Tomkiewicz R, et al. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease. Am J Respir Crit Care Med 1997; 156:173-177
10. Tomkiewicz RP, Kishioka C, Freeman J, et al. DNA and actin filament ultrastructure in cystic fibrosis sputum. In: Baum G. ed. Cilia, mucus, and mucociliary interactions. New York, NY; Marcel Dekker, 1988; 333-341
11. Sheils CA, Kas J, Travassos W, et al. Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol 1996; 148:919-927
12. Sanders MC, Goldstein AL, Wang Y-L. Thymosin β4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci U S A 1992; 89:4678-4682
13. Safer D, Nachmias VT. β Thymosins as actin binding peptides. BioEssays 1994; 16:473-479
14. Carlier M-F, Didry D, Erk I, et al. Thymosin β 4 is not a simple G-actin sequestering protein and interacts with F-actin at high concentration. J Biol Chem 1996; 271:9231-9239
15. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70:6524-6533
16. Sosne G, Szliter EA, Barrett R, et al. Thymosin β4 promotes corneal wound healing and decreases inflammation in vitro following alkali injury. Exp Eye Res 2002; 74:293-299
17. Shah SA, Santago P, Rubin BK. Quantification of biopolymer filament structure. Ultramicroscopy 2005; 104:244-254
18. Shah PL, Scott SF, Knight RA, et al. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax 1996; 51:119-125
19. Bush A, Payne D, Pike S, et al. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest 2006; 129:118-123
20. ASTM (American Society for Testing of Materials). D3121-94, 1999: standard test method for tack of pressure-sensitive adhesives by rolling ball. ASTM International. 10-Oct-1999.
21. Rubin BK. Surface properties of respiratory secretions: relationship to mucus transport. In: Baum G, ed. Cilia, mucus, and mucociliary interactions. New York, NY: Marcel Dekker, 1998; 317-324
22. Zahm JM, Puchelle E, Duvivier C, et al. Spinability of respiratory mucous: validation of a new apparatus; the Filancemeter. Bull Eur Physiopathol Respir 1986; 22:609-613
23. Albers GM, Tomkiewicz RP, May MK, et al. Ring distraction technique for measuring the surface tension of sputum and relationship of the work of adhesion to clearability. J Appl Physiol 1996; 81:2690-2695
24. Agarwal M, King M, Rubin BK, et al. Mucus transport in a miniaturized simulated cough machine: effect of constriction and serous layer simulant, Biorheology 1989; 26:977-988
25. Rubin BK, Ramirez O, King M. Mucus-depleted frog palate as a model for the study of mucociliary clearance. J Appl Physiol 1990; 69:424-429
26. Safer D, Elzinga M, Nachmias VT. Thymosin β4 and Fx, an actin sequestering peptide, are indistinguishable. J Biol Chem 1991; 266:4029-4032
27. Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 2005; 11:421-429
28. Huff T, Christian SG, Muller AM. β-Thymosins, small acidic peptides with multiple functions. Int S Biochem Cell Biol 2001; 33:205-220
29. Ferry JD. Molecular theory for undiluted polymers and concentrated solutions: networks and entanglements. In: Viscoelastic properties of polymers. 2nd ed. New York, NY: Wiley, 1970; 268-270
30. Davoodian K, Ritchings BW, Ramphal R, et al. Gelsolin activates DNase I in vitro in cystic fibrosis sputum. Biochemistry 1997; 36:9637-9641
31. Lazarides E, Lindberg U. Acttn is the naturally occurring inhibitor of deoxyribonuclease I. Proc Nat Acad Sci U S A 1974; 71:4742-4746
32. Zahm JM, Debordeaux C, Maurer C, et al. Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions. Am J Respir Crit Care Med 2001; 163:1153-1157
33. Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354:229-240
34. Donaldson SH, Bennett WD, Zeman KL, et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006; 354:241-250